Skip to main content
Premium Trial:

Request an Annual Quote

Blue Heron Wins $770K Phase II SBIR Grant for Large DNA Fragment Assembly Method

NEW YORK, March 14 (GenomeWeb News) - Blue Heron Biotechnology has been awarded a Phase II Small Business Innovation Research grant to help it develop methods for assembling very large recombinant DNA molecules, Blue Heron said yesterday.


The $769,250 grant was awarded by the National Institute of General Medical Science and the National Human Genome Research Institute, and follows a Phase I SBIR grant awarded in September 2004. That grant was awarded to help the company develop and demonstrate a restriction technology that allows the release of any cloned fragment, regardless of its length or the presence of conventional restriction sites.


Blue Heron, based in Bothell, Wash., said that if the Phase II research is successful, it will allow the company to extend its GeneMaker gene synthesis service to produce fragments of 100,000 base pairs or more.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.